Medical Condition News

RSS

Inflammation markers not involved with the chemopreventative effect of aspirin on colorectal adenomas

Unexpectedly, inflammation markers do not appear to be involved with the chemopreventative effect of aspirin on colorectal adenomas, according to a brief communication published online October 12 in the Journal of the National Cancer Institute.

13 Oct 2009

FirstCare Texas to provide Vermedx Diabetes Information System to health care providers and patients

FirstCare Texas has signed a contract with Vermedx, Inc. to provide its patent-pending Vermedx Diabetes Information System (VDIS) for the use of health care providers and patients belonging to First Care Health Plan's health maintenance organization operating in Lubbock, Waco, Abilene, and Amarillo, Texas.

13 Oct 2009

Report shows that visual impairments are associated with the risk of death in older adults

Visual problems that cannot be corrected are associated with increased risk of death among individuals between the ages of 49 and 74, and all visual impairments may be associated with the risk of death in older adults, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

13 Oct 2009

Brookstone launches anti-snore pillow

Enjoy a peaceful night's sleep and significantly decrease the rhythmic, strident sound of your partner's incessant snoring with the Brookstone Anti-Snore Memory Foam Pillow. The specialty retailer and product development company recently launched its anti-snore pillow with a clinically tested design helpful in reducing snoring and providing comfort without altering your natural sleep style or position.

13 Oct 2009

Legendary coach helps raise awareness on osteoarthritis

After leading the U.S. men’s basketball team to Olympic gold last year and two weeks before the start of his 30th season as head coach of Duke University’s men’s basketball team, Mike Krzyzewski (Coach K), 61, is teaming up with the Arthritis Foundation to help raise awareness of the disease that nearly ended his coaching career 10 years ago.

13 Oct 2009

Public lecture at UC Riverside to focus on the evolutionary struggle for cancer

Cancer is a leading cause of death worldwide. Our evolutionary struggle with this disease is the focus of a free, public lecture at UC Riverside.

13 Oct 2009

Cognitive abilites other than memory may decline prior to clinical diagnosis in patients with Alzheimer's disease

Cognitive abilities other than memory, including visuospatial skills needed to perceive relationships between objects, may decline years prior to a clinical diagnosis in patients with Alzheimer's disease, according to a report in the October issue of Archives of Neurology, one of the JAMA/Archives journals.

13 Oct 2009

Study demonstrates coexistence of visuospatial and phonological disorders in dyslexics

Chinese-speaking children with dyslexia have a disorder that is distinctly different, and perhaps more complicated and severe, than that of English speakers. Those differences can be seen in the brain and in the performance of Chinese children on visual and oral language tasks, reveals a report published online on October 12th in Current Biology, a Cell Press publication.

13 Oct 2009

A new site and blog for dieters to share information launched by DietReality.com

In response to an increasing need to provide up-to-date information on safe and effective weight loss products, DietReality.com has launched a new site and blog designed to empower dieters to share information.

12 Oct 2009

SCAA honors San Diego Project Heart Beat with 2009 Public Service Award

October is Sudden Cardiac Arrest Awareness Month, and the Sudden Cardiac Arrest Association (SCAA) honored San Diego Project Heart Beat with the 2009 Public Service Award for its work to raise awareness of sudden cardiac arrest (SCA), prevent sudden cardiac death and improve cardiovascular health.

12 Oct 2009

Low birth weight children face higher risk of developing asthma later in life

A new study from the medical university Karolinska Institutet in Stockholm shows that children born with low birth weight are at a higher risk of developing asthma later in life.

12 Oct 2009

Researchers identify genes that play a role in the development of endometrial cancer

Researchers at the University of Gothenburg, Sweden, have identified two genes believed to play a role in the development of endometrial cancer. These results may eventually lead to better diagnosis and treatment of this increasingly common form of cancer.

12 Oct 2009

FDA grants marketing approval for CSL Behring's Berinert C1-Esterase Inhibitor

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.

12 Oct 2009

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Clinical experience with the FDA cleared Axxent® Electronic Brachytherapy, eBx(TM), System from Xoft shows promise for the multi-disciplinary use of the isotope-free cancer treatment platform to deliver intraoperative radiation therapy (IORT). Xoft will showcase a variety of investigational IORT oncology applications at the American College of Surgeons 95th Annual Clinical Congress here in Chicago, October 11-15, 2009.

12 Oct 2009

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that additional results from its Phase 3 trial (SYMMETRYSM) of elesclomol in combination with paclitaxel in metastatic melanoma was presented at the Perspectives in Melanoma XIII Conference by Steven O’Day, M.D., principal investigator and Chief of Research and Director of the Melanoma Program at the Angeles Clinic in Santa Monica, California.

12 Oct 2009

The Hallowell Centers include beneficial exercises in treatment of ADHD

New brain research is unlocking long-standing mysteries, explaining how the brain trains itself and how human beings develop their superior cognitive skills. New scanning tools (FMRI, SPECT, QEEG, etc.) are advancing neurology's understanding of a process called neuroplasticity and shedding light on a simple looking balance and movement regimen used since 1982 by developmental specialists to treat people with ADHD, Dyslexia and other learning differences.

12 Oct 2009

Holistic care needed for people with Alzheimer's disease and dementia

Whilst cognitive function can be improved by the medicines currently available for the treatment of dementias, the positive effects of improved socialibility, initiative and motivation on the patient and their carer as well as their capability of coping with everyday life should not be overlooked says a research report published by the Pharmacy Practice Research Trust (the Trust).

12 Oct 2009

Rice consumption improves overall diet and reduces obesity and Type II diabetes

According to recent research published in the October issue of the Journal of the American Dietetic Association (JADA), eating rice helps improve overall diet and potentially reduces the risk for many chronic diseases, including obesity, cardiovascular disease and Type II diabetes.

12 Oct 2009

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza

ImmuneRegen BioSciences, Inc.®, a wholly owned subsidiary of IR Biosciences Holdings, Inc. (OTCBB: IRBS), today announced that its lead anti-influenza drug, Homspera, will be tested for efficacy against highly lethal H5N1 Avian Influenza in the laboratories of a widely respected University scientist. Additionally, testing at an independent facility will further define the adjuvant efficacy of Homspera when coupled with a novel vaccine for H5N1 in studies sponsored by an ImmuneRegen industry partner.

12 Oct 2009

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

Celator Pharmaceuticals today announced that it has completed enrollment in its Phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus conventional cytarabine and daunorubicin therapy ("7+3") in patients 60-75 years of age with untreated acute myeloid leukemia (AML).

12 Oct 2009

Medical Condition News

Inflammation markers not involved with the chemopreventative effect of aspirin on colorectal adenomas

FirstCare Texas to provide Vermedx Diabetes Information System to health care providers and patients

Report shows that visual impairments are associated with the risk of death in older adults

Brookstone launches anti-snore pillow

Legendary coach helps raise awareness on osteoarthritis

Public lecture at UC Riverside to focus on the evolutionary struggle for cancer

Cognitive abilites other than memory may decline prior to clinical diagnosis in patients with Alzheimer's disease

Study demonstrates coexistence of visuospatial and phonological disorders in dyslexics

A new site and blog for dieters to share information launched by DietReality.com

SCAA honors San Diego Project Heart Beat with 2009 Public Service Award

Low birth weight children face higher risk of developing asthma later in life

Researchers identify genes that play a role in the development of endometrial cancer

FDA grants marketing approval for CSL Behring's Berinert C1-Esterase Inhibitor

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Synta Pharmaceuticals updates its Phase 3 SYMMETRY trial results at the Melanoma XIII Conference

The Hallowell Centers include beneficial exercises in treatment of ADHD

Holistic care needed for people with Alzheimer's disease and dementia

Rice consumption improves overall diet and reduces obesity and Type II diabetes

ImmuneRegen BioSciences to test efficacy of Homspera against H5N1 Avian Influenza

Celator Pharmaceuticals enrolls 120 patients in CPX-351 Phase 2 study

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News